Vancouver, British Columbia–(Newsfile Corp. – February 5, 2021) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) has promoted Orville Bovenschen to the position of...
Vancouver, British Columbia–(Newsfile Corp. – January 13, 2021) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) today announced that it has settled all outstanding...
Vancouver, British Columbia–(Newsfile Corp. – December 29, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) today announced that its partner, STENOCARE A/S, completed...
Vancouver, British Columbia–(Newsfile Corp. – December 17, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) has launched and made its first shipment of...
Vancouver, British Columbia–(Newsfile Corp. – December 4, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) today announced that it has terminated its share...
Emerald hosting conference call today, December 1st, at 10:30 am ET Vancouver, British Columbia–(Newsfile Corp. – December 1, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH)...
Emerald to report Q3 financial results on November 30th and host conference call on December 1st at 10:30 am ET Vancouver, British Columbia–(Newsfile Corp. – November...
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) has completed the previously disclosed sale of...
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) has completed the previously disclosed sale...
Vancouver, British Columbia–(Newsfile Corp. – October 29, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) is pleased to announce that its shareholders...